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The quaking viable (qkv) mice represent an animal model of dysmyelination. The absence of expression of the QKI-6 and QKI-7
cytoplasmic isoforms in oligodendrocytes (OLs) during CNS myelination causes the qkv mouse phenotype. The QKI
RNA-binding proteins are known to regulate RNA metabolism of cell cycle proteins and myelin components in OLs;
however, little is known of their role in reorganizing the cytoskeleton or process outgrowth during OL maturation and
differentiation. Here, we identify the actin-interacting protein (AIP)-1 mRNA as a target of QKI-6 by using two-dimensional
differential gel electrophoresis. The AIP-1 mRNA contains a consensus QKI response element within its 3-untranslated
region that, when bound by QKI-6, decreases the half-life of the AIP-1 mRNA. Although the expression of QKI-6 is known
to increase during OL differentiation and CNS myelination, we show that this increase is paralleled with a corresponding
decrease in AIP-1 expression in rat brains. Furthermore, qkv/qkv mice that lack QKI-6 and QKI-7 within its OLs had an
increased level of AIP-1 in OLs. Moreover, primary rat OL precursors harboring an AIP-1 small interfering RNA display
defects in OL process outgrowth. Our ﬁndings suggest that the QKI RNA-binding proteins regulate OL differentiation by
modulating the expression of AIP-1.
INTRODUCTION
The quaking viable (qkv) mice harbor an autosomal reces-
sive deletion encompassing part of the qkI locus (Ebersole
et al., 1996b). These mice represent an animal model of
CNS dysmyelination, because they display rapid tremors
that are especially pronounced in their hind limbs. The
oligodendrocytes (OLs) of the qkv mice display a matura-
tion defect and as a result do not properly compact myelin
(Hogan and Greenﬁeld, 1984). The exact reason that OLs
from the qkv mice fail to mature is unknown; however, it
is likely that there is a premature cessation of the OL
differentiation due to defective RNA regulation (Chenard
and Richard, 2008).
The qkI gene expresses three major alternatively spliced
mRNAs (5, 6, and 7 kb) encoding QKI-5, QKI-6, and QKI-7
that differ in their C-terminal 30 amino acids (Ebersole et
al., 1996b). The QKI-5 unique sequence contains a nuclear
localization signal that renders this isoform exclusively
nuclear (Wu et al., 2002). QKI-6 and QKI-7 are cytoplasmic
(Pilotte et al., 2001) and in mice, their expression coincides
with the process of myelination during the ﬁrst two post-
natal weeks (Ebersole et al., 1996a). The genetic deletion in
qkv mice prevents the expression of the QKI-6 and QKI-7
isoforms in OLs, resulting in a dysmyelination phenotype
(Ebersole et al., 1996b; Hardy et al., 1996a) and implying
that the QKI-6 and QKI-7 isoforms play a key role in
myelination. Indeed, the forced expression of QKI-6 and
QKI-7 induces OL differentiation and maturation (La-
rocque et al., 2005). Moreover, a transgenic allele that
expresses QKI-6 speciﬁcally in the OL lineage rescues the
dysmyelination phenotype of qkv mice (Zhao et al., 2006b).
The QKI proteins belong to the heteronuclear ribonu-
cleoprotein particle K homology domain family of RNA-
binding proteins that bind RNA with sequence speciﬁcity
and high afﬁnity (Lee and Schedl, 2006; Lukong et al.,
2008; Volk et al., 2008). The QKI proteins selectively inter-
act with a short sequence termed the QKI response ele-
ment [QRE; ACUAAY (N1-20) UAAY] (Galarneau and
Richard, 2005) frequently located in the 3-untranslated
region (UTR) of the target mRNAs. Functional QREs have
been identiﬁed in the mRNAs of myelin basic protein
(MBP) (Li et al., 2000; Larocque et al., 2002), Krox-20
(Egr-2) (Nabel-Rosen et al., 2002; Galarneau and Richard,
2005), microtubule-associated protein 1B (Zhao et al.,
2006a), and the cyclin-dependent kinase inhibitor p27KIP1
(Larocque et al., 2005). Many other mRNAs are predicted
to be regulated by QKI, because a bioinformatics analysis
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3029led to the identiﬁcation of 1433 mRNAs that contain at
least one QRE (Galarneau and Richard, 2005). Gene on-
tology annotation identiﬁed development as a major cat-
egory of putative QKI RNA targets, consistent with the
dysmyelination phenotype of the qkv mice (Galarneau and
Richard, 2005). Another category that was identiﬁed was
cell adhesion (Galarneau and Richard, 2005), but a func-
tional link between the QKI proteins and mRNAs encod-
ing proteins regulating cell adhesion remains undeﬁned.
To identify QKI-6–regulated targets, we introduced QKI-6
in CRL2020, a QKI-deﬁcient glioblastoma multiforme cell
line. Cellular extracts were prepared from QKI-6 expressing
CRL2020 and a control green ﬂuorescent protein (GFP) ex-
pressing CRL2020. Each extract was labeled, and the differ-
entially expressed proteins were identiﬁed by two-dimen-
sional difference gel electrophoresis (2D-DIGE), followed by
mass spectrometry. We identiﬁed several cytoskeletal pro-
teins, including AIP-1, tropomyosin (TPM)1, Actin, 1
(ACTG1), and lamin B1 that are regulated by QKI-6. These
ﬁndings are consistent with cell adhesion as being a major
annotation category of the QKI RNA targets that we identi-
ﬁed by using SELEX and bioinformatics (Galarneau and
Richard, 2005). We conﬁrmed that the AIP-1 mRNA is an
RNA target for QKI-6. Moreover, we show that the AIP-1
mRNA levels are regulated in puriﬁed OLs and during CNS
myelination. These ﬁndings deﬁne a new regulatory net-
work in OLs controlled by the QKI proteins.
MATERIALS AND METHODS
Antibodies
The anti-myc (9E10) and A2B5 mouse monoclonal antibodies were obtained
from the American Type Culture Collection (Manassas, VA). Antibodies
against -tubulin and -actin were purchased from Sigma-Aldrich (St. Louis,
MO). The QKI-6 antibodies were raised in rabbits by using the peptide
KEYPIEPSGVLGMAFPTKG. Anti-AIP-1 was purchased from Aviva Systems
Biology (San Diego, CA). Anti-voltage-dependent anion channel 2 (VDAC2)
polyclonal and nucleophosmin 1 (NPM1) were from Abcam (Cambridge,
MA). Anti-TPM3 was purchased from Abnova (Walnut, CA).
2D-DIGE
The patient derived glioblastoma multiforme CRL2020 cell line was pur-
chased from American Type Culture Collection (Mulholland et al., 2006).
These cells were transduced for2di ntriplicates with either AdGFP or
AdQKI-6, as described previously (Larocque et al., 2002). Differentially ex-
pressed protein spots were selected, picked, and identiﬁed by mass spectrom-
etry by Applied Biomics (Hayward, CA).
QKI Knockdown in U343
U343 glioblastoma cell lines were transfected with siGENOME SMARTpool
small interfering RNA (siRNA) targeting the mRNA for the QKI isoforms or
siGFP (5-GCT GAC CCT GAA GTT CAT CTG CGT-3) as control for 2 d,
followed by cell harvesting in Laemmli buffer. Lipofectamine RNAiMAX
transfection reagent was used according to manufacturer’s protocol (Invitro-
gen, Carlsbad, CA). siQKI (M-104651-00-0010) was purchased from Dharma-
con RNA Technologies (Lafayette, CO).
Electrophoretic Mobility Shift Assay
Synthetic RNAs were prepared by runoff in vitro transcription using T7
MegaShortscript (Ambion, Austin, TX) according to the manufacturer’s pro-
tocols. A constant concentration of 32P-labeled RNA (100 pmol) was incubated
Figure 1. Two-dimensional DIGE identiﬁes QKI-6–regulated targets in glioblastoma cells. (A) The differential protein expression between
AdGFP-infected and AdQKI-6–infected CRL2020 cells was identiﬁed by 2D-DIGE. The unique protein spots (green or red, not yellow) were
picked and identiﬁed by mass spectrometry. The molecular mass markers are shown on the ordinate in kilodaltons, and the isoelectric point
is shown on the abscissa. Four representative unique spots were enlarged on the right, which were identiﬁed via mass spectrometry as AIP-1,
VDAC2, TPM3, and NPM1. (B) Protein extracts from AdGFP and AdQKI-6 were analyzed by SDS-polyacrylamide gel electrophoresis
followed by immunoblotting with anti-AIP-1, -VDAC2, -TPM3, and -NPM1 antibodies. Anti--tubulin antibodies were used to conﬁrm
equivalent protein expression. Anti-myc and -QKI-6 antibodies conﬁrmed the expression of the myc-epitope–tagged QKI-6. The data shown
are representative of three independent experiments and normalized to -tubulin protein levels. The relative amounts are presented
underneath each blot and were performed using Scion-Image (Scion, Frederick, MD). The standard deviations for VDAC2, TPM3, and NPM1
are 0.1, 0.12, and 0.09, respectively. (C) Knockdown of QKI-6 was performed using siRNA against QKI or control siRNA against GFP.
Protein extracts from siQKI and siGFP were analyzed by SDS-PAGE followed by immunoblotting with anti-AIP-1 and -QKI-6 antibodies.
Anti--tubulin antibodies were used to conﬁrm equivalent protein expression. Absolute quantiﬁed levels of protein bands are presented
underneath each blot and were performed using Scion-Image.
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trations (100 nM, 300 nM, and 1 M) of GST-QKI-6 or GST-QKI-6:V157E
mutant in the following buffer: 20 mM HEPES, pH 7.4, 330 mM KCl, 10 mM
MgCl2, 0.1 mM EDTA, 0.1 mg/ml heparin, and 0.01% IGEPAL CA630 [Sigma-
Aldrich]). The 30-l reactions were incubated at room temperature for 1 h,
and then 3.3 l of RNA loading dye was added to each sample. Next, 20 lo f
each sample was separated on native Tris-glycine 8% acrylamide gels. The
gels were dried and the bound, and unbound RNAs were analyzed using a
Storm PhosphorImager (GE Healthcare, Baie-d’Urfe, QC, Canada).
Luciferase (Luc) Assays
The 3-UTR of AIP-1 was ampliﬁed using the following primers (5-AAT CAA
GCT TAC GCA AAA ACA CTC CCA ATC-3 and 5-AAT CAC TAG TCT
CTG GAT GGA CCG AAT CAG-3) from the human AIP-1 full-length clone
(Origene, Rockville, MD) and cloned into the pMIR-REPORT luciferase vector
(Ambion). Human embryonic kidney (HEK)293 cells were cotransfected with
either empty pMIR luciferase, the pLuc:AIP-1 3-UTR, or the pLuc:AIP-1
3-UTR with the mutated QRE along with either pcDNA (control), pcDNA-
myc-QKI-6, or pcDNA-myc-QKI-6:V157E. pRLTK (Promega, Madison, WI)
encoding Renilla luciferase was used to control transfection efﬁciency. The cell
extracts were harvested 48 h after transfection, and luciferase activity was
assayed using the Dual-Luciferase Reporter Assay kit (Promega) and mea-
sured using the GloMax 20/20 luminometer (Promega).
In Vivo RNA Binding Assay
CRL2020 cells transduced with AdQKI-6 were harvested in lysis buffer (0.1%
Triton X-100, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1 mg/ml heparin, and
0.5 U/l RNasin). The lysates were immunoprecipitated with anti-myc anti-
body or immunoglobulin (Ig)G. RNA was isolated using TRIzol isolation
reagent (Invitrogen) according to the manufacturer’s protocol. Reverse tran-
scription assays were performed using SuperScript II Reverse Transcriptase
(Invitrogen). The sequences of the primers used were as follows: AIP-1,
5-CAT TCC TTT GAA ATA AGG TT-3 and 5-AAA TAT GTA CTA CGG
AAT TA-3; p27KIP1,5 -CCT TCC CCA AAA TTG CTT CT-3 and 5-CCG
GCT AAC TCT GAG GAC AC-3; and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH), 5-AGG GGT CTA CAT GGC AAC TG-3 and 5-GTC AGT
GGT GGA CCT GAC CT-3.
Real-Time Polymerase Chain Reaction (PCR)
Real-time PCR reactions were performed on the 7300 Real-Time PCR System
(Applied Biosystems, Foster City, CA) using SYBR Green PCR Master Mix
(QIAGEN, Valencia, CA). Data analysis was performed using Real-Time PCR
software 7500 version 2.0.1 (Applied Biosystems). The relative concentrations
of the genes of interest were determined using the comparative Ct method
after normalizing to the endogenous control (GAPDH). Primers from QIAGEN
were as follows: TPM3, Hs_TPM3_2_SG; VDAC2, Hs_VDAC2_2_SG; AIP-1,
Hs_WDR1_2_SG; NPM1, Hs_NPM1_2_SG; Actin, Hs_ACTB_2_SG; p27KIP1,
Hs_CDKN1B_2_SG; and GAPDH, Hs_GAPDH_2_SG.
mRNA Half-Life Analysis
Total RNA was isolated from CRL2020 cell lines transduced with either
AdGFP or AdQKI-6 for 24 h and treated with 5 g/ml actinomycin D from 0
Figure 2. The AIP-1 mRNA is reduced with
QKI-6 expression. Total RNA was harvested
after infection of AdGFP or AdQKI-6 into
CRL2020 cells. mRNA expression of AIP-1
(A), TPM3 (B), VDAC2 (C), NPM1 (D), and
actin (E) was assayed by real-time PCR. The
results shown represent triplicate analyses of
each target. GAPDH was used as an internal
control for RNA level normalization. One-
way analysis of variance was performed; sin-
gle asterisks denotes a p  0.05 and double
asterisks denote a p  0.005.
Table 1. Putative targets of QKI-6 identiﬁed by 2D-DIGE
Gene Gene name
Volume ratio
QKI-6:GFP
ACO2 Aconitase 2, mitochondrial 1.5
ACTB A chain structure of crystalline
proﬁlin--actin
1.8
ACTG1 Actin, 1 1.9
AIP-1 Actin-interacting protein 1.6
ANXA2 Annexin 2A 1.9
CAPZB Capping protein (actin ﬁlament)
muscle Z-line, 
3.1
CCT6A Chaperonin containing TCP1,
subunit 6A (1)
1.6
Eef2 Eukaryotic translation elongation
factor 2
1.9
GANAB Glucosidase  neutral AB 1.9
GSN Gelsolin 1.7
HNRNPH3 Heterogeneous nuclear
ribonucleoprotein H3 isoform A
2.3
HSPA2/8 Heat-shock 70-kDa protein 2 and
8
2.1
HSPD1 Heat-shock 60-kDa protein 1
(chaperonin)
1.8
Lamin B1 Lamin B1 2.5
NPM1 Nucleophosmin 1.7
PKM2 Pyruvate kinase 2
PYGB Phosphorylase brain glycogen 2.3
TPI Triosephosphate isomerase 1 1.8
TPM3 Tropomyosin 3 1.6
VDAC2 Voltage-dependent anion
channel 2
6.1
XRCC2 XRCC2 DNA repair protein 1.7
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by real-time PCR with the following primers from QIAGEN: AIP-1,
Hs_WDR1_2_SG; Actin, Hs_ACTB_2_SG; p27KIP1, Hs_CDKN1B_2_SG; and
GAPDH, Hs_GAPDH_2_SG.
OL AIP-1 Localization and Actin Filament Localization
Primary OL precursor cells were isolated, puriﬁed, and differentiated as
described previously (Almazan et al., 1993). For nonphalloidin staining, 4%
paraformaldehyde ﬁxation was used followed by permeabilization in 0.5%
Triton X-100 and blocking in 10% goat serum. For actin ﬁlament staining, cells
were rinsed in a cytoskeletal buffer containing 137 mM NaCl, 5 mM KCl, 1
mM Na2HPO4, 0.4 mM KH2PO4, 5.5 mM glucose, 4 mM NaHCO3,2m M
MgCl2, 2 mM EGTA, and 10 mM MES, pH 6.1 (Webb et al., 1995). The cells
were then ﬁxed and permeabilized in the cytoskeletal buffer, supplemented
with 0.5% Triton X-100 and 0.25% glutaraldehyde for 10 min at room tem-
perature, followed by a more stringent ﬁxation in cytoskeletal buffer with 1%
glutaraldehyde for 10 min at room temperature. After ﬁxation, cells were
blocked with 10% goat serum for 15 min at room temperature before incu-
bation with phalloidin conjugated to Alexa 488 (500 nM) for 30 min at room
temperature. Images were acquired using AxioImager 2 upright microscope
(Carl Zeiss, Jena, Germany) and prepared using AxioVision 4.8.1 software
(Carl Zeiss).
OL Total mRNA Analysis and mRNA Half-Life
Total RNA was isolated using the TRIzol (Invitrogen) from rat primary oligo-
dendrocyte precursor cells (OPCs). mRNA half-life analysis was performed on
puriﬁed rat primary OPCs differentiated for two time points (0 and 4 d) and
treated with 5 g/ml actinomycin D for 0–24 h. First-strand cDNA synthesis and
Figure 3. QKI-6 associates with the AIP-1
mRNA and decreases its half-life. Total RNA
was harvested after infection of AdGFP or
AdQKI-6 into CRL2020 cells treated with ac-
tinomycin D for the indicated times. The lev-
els of AIP-1 (A), p27KIP1 (B), and actin (C)
mRNA normalized to levels of GAPDH were
examined by real-time PCR. Two-way analy-
sis of variance was performed in comparison
with AdGFP; single asterisks denotes a p 
0.05 and double asterisks denote a p  0.005.
Figure 4. The AIP-1 3-UTR harbors a QKI
response element (QRE). (A) The sequence of
the human AIP-1 3-UTR from nucleotides
2902–2944 is shown. The underlined and bold
sequences denote the half-site and core QKI
binding sites from left to right. The mutant
AIP-1 sequences with mutations at the QRE
sites are shown underlined and italicized. (B)
Radioactive labeled RNA probes of the se-
quences shown in A were incubated with pro-
tein-RNA binding buffer alone (buffer), with
GST, or with increasing amounts of GST-
QKI-6. The samples were incubated at room
temperature for 1 h and then separated by 8%
Tris borate-EDTA-polyacrylamide gel electro-
phoresis gel. The migration of the QKI-6/
RNA complex and free RNA probe is indi-
cated. (C) CRL2020 cells transduced with
AdQKI-6 were lysed and protein–RNA inter-
actions examined by coimmunoprecipitation.
Cell extracts were lysed and incubated with IgG
as a control and anti-myc antibodies to immu-
noprecipitate myc-epitope–tagged QKI-6. The
QKI-6 bound RNA and input RNA were analyzed by semiquantitative RT-PCR, and the DNA fragments separated on a 2% agarose gel and
visualized by ethidium bromide staining.
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following oligonucleotide primers used for puriﬁed OLs total and half-life
mRNA assay were ordered from QIAGEN: Actin, Rn_Actg1_1_SG; GAPDH,
Rn_Gapd_1_SG; AIP-1, Rn_Wdr1_1_SG; p27KIP1, Rn_Cdkn1b_2_SG; and MBP,
Rn_Mbp_1_SG. Id2 primers were ordered from Invitrogen: 5-GGA CAG AAC
CAA ACG TCC AG-3 and 5-TAA GCT CAG AAG GGA ATT CAG-3.
AIP-1 Knockdown in OLs
Puriﬁed OPCs were transfected with siGLO and siGENOME SMARTpool
siAIP-1 or siGLO and sipGL2 (5-CGT ACG CGG AAT ACT TCG A-3) for
2 d, followed by a second siRNA treatment. siIMPORTER Transfection re-
agent (Millipore, Billerica, MA) was used according to the protocol provided
for adherent cells. Twelve hours after the second siRNA treatment, the culture
media were changed to either serum-free media (SFM) with growth factors or
into SFM supplemented with T3 to promote differentiation. Quantiﬁcation of
cell types in sipGL2- or siAIP-1–transfected cells was determined by mor-
phology and immunostaining using A2B5 antibodies. Approximately 50 cells
from each triplicate of siAIP-1 and sipGL2 transfection were assessed for the
presence of secondary branching. siGENOME SMARTpool siAIP-1 (M-
085115-00-0010) and siGLO (D-001600-01-05) were purchased from Dharma-
con RNA Technologies. Images were acquired using AxioImager 2 upright
microscope (Carl Zeiss) and prepared using AxioVision 4.8.1 software (Carl
Zeiss).
Animals
Animals were killed in accordance with a protocol approved by the Animal Care
Committee at McGill University. qkv/qkv mice were obtained from JAX laborato-
ries (Bar Harbor, ME) and maintained on a C57BL/6 background. The qkv
mutation was ampliﬁed using primers directed against the breakpoint (5-TCT
AAA GAG CAT TTT CGA AGT-3) and (5-TTG CTA ACT GAA TAT TAC
T-3). Rat brains were weighed and solubilized in ice-cold lysis buffer (1:5,
wt/vol) containing 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, and
protease inhibitor cocktail (Roche, Laval, QC, Canada). Brains were homoge-
nized by pulse sonication at 15-s intervals on ice, followed by centrifugation at
16,000  g for 20 min. Supernatant protein concentrations were determined by
bicinchoninic acid assay according to manufacturer’s instructions (Thermo Fisher
Scientiﬁc, Waltham, MA).
Immunocytochemistry
Mice were anesthetized with isoﬂurane and perfused with ice-cold phos-
phate-buffered saline followed by 4% paraformaldehyde. Brains were cryo-
protected in 30% sucrose overnight at 4°C and embedded in OCT compound
(Tissue-Tek, Markham, ON, Canada) over dry ice in acetone. Tissues were
cryostat sectioned at 6 m and collected on / slides (Fisher, Ottawa, ON,
Canada). Tissue sections were blocked in 10% goat serum in Tris-buffered
saline  0.5% Triton X-100 for 1 h followed by incubation with primary
antibodies overnight at room temperature. Slides were incubated with Alexa-
Flour 488 or 546 IgG at a dilution of 1:400 for 4 h.
RESULTS
Identiﬁcation of Cellular Proteins Modulated by QKI-6
Expression Using 2D-DIGE
The QKI isoforms are sequence-speciﬁc RNA-binding pro-
teins (Ryder and Williamson, 2004; Galarneau and Richard,
2005) known to modulate various aspects of RNA metabo-
lism in myelinating cells (Chenard and Richard, 2008); how-
ever, few physiological QKI RNA targets are known. To
identify QKI RNA targets, we reasoned that the mRNA and
protein levels of certain targets would be modulated by the
expression of the QKI isoforms. The QKI-deﬁcient glioblas-
Figure 5. The 3-UTR of AIP-1 confers
QKI-6 sensitivity to a heterologous RNA. (A)
Schematic illustration of pMIR-reporter vec-
tors with or without the 3-UTR of AIP-1, as
well as with a mutated QRE version of the
AIP-1 3-UTR. (B) HEK293 cells were cotr-
ansfected with pcDNA, pcDNA-QKI-6, or
pcDNA-QKI-6:V157E, along with the indi-
cated pMIR-reporter vectors and pTKrenilla
to control for transfection efﬁciency. The lu-
ciferase activity was expressed as a normal-
ized ratio of the activity of luciferase/Renilla
( represents the SE of the mean). Each bar
represents three separate experiments. One-
way analysis of variance was performed in
comparison with absence of QKI-6 transfec-
tion. Single asterisk denotes a p  0.005.
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was transduced with a control adenovirus expressing GFP
(AdGFP) or an adenovirus expressing myc-epitope–tagged
QKI-6 and GFP (AdQKI-6). We focused on the QKI-6 iso-
form, because it has been shown to rescue the phenotype of
the qkv mice (Zhao et al., 2006b). Approximately 95% of the
cells infected with AdGFP or AdQKI-6 expressed GFP, a
marker of infection. The cellular extracts were differentially
labeled with ﬂuorescent dyes and analyzed by 2D-DIGE
(Figure 1A). The analysis revealed 21 putative QKI-6-regu-
lated targets, 12 of which were up-regulated and nine of
which were down-regulated. The putative QKI-6 targets
were analyzed by mass spectrometry (Table 1). By using
immunoblotting analysis, we conﬁrmed the decrease in
AIP-1, VDAC2, TPM3, and NPM1 with the ectopic expres-
sion of the QKI-6 isoform (Figure 1B). The expression of the
myc-epitope–tagged QKI-6 was conﬁrmed by immunoblot-
ting with anti-myc and -QKI-6 antibodies, whereas anti--
tubulin antibodies were used to demonstrate equivalent
loading (Figure 1B).
As an additional control for our 2D-DIGE analysis, we
also assessed whether knockdown of the QKI-6 isoform in
the U343 glioma cell line would affect expression of AIP-1 as
this target was found to be most highly regulated in
CRL2020 by exogenous QKI-6. Immunoblotting analysis of
control knockdown, siGFP, compared with siQKI showed a
threefold decrease in QKI-6 levels and a sevenfold increase
in levels of AIP-1 after QKI knockdown normalized to -tu-
bulin levels, further conﬁrming our initial 2D-DIGE analysis
(Figure 1C).
We next assessed whether QKI-6 also decreased the ex-
pression levels of the AIP-1, TPM3, VDAC2, and NPM1
mRNAs by using quantitative real-time reverse transcrip-
tion (RT)-PCR. The mRNA levels of AIP-1 and TPM3 were
signiﬁcantly reduced with the expression of QKI-6 (Figure 2,
A and B), whereas the mRNA levels of the VDAC2, NPM1,
and the control -actin were not signiﬁcantly (n.s.) altered
by QKI-6 expression (Figure 2, C–E). These ﬁndings suggest
that QKI-6 may modulate the posttranscriptional regulation
of AIP-1 and TPM3 mRNAs. We selected AIP-1 for further
study, because it was the target that seemed to be most
sensitive to QKI-6 expression while also harboring the con-
sensus QRE sequences within its 3-UTR.
QKI-6 Leads to AIP-1 mRNA Destabilization
We examined whether QKI-6 regulates the half-life of the
AIP-1 mRNA by treating AdGFP- and AdQKI-6–transduced
CRL2020 cells with actinomycin D and measuring the half-
life of the AIP-1 mRNA by real-time PCR. We showed
previously that the QKI-6 isoform stabilizes the mRNA en-
coding p27 KIP1 (Larocque et al., 2005), and we monitored the
half-life of mRNAs encoding p27KIP1 and -actin, as positive
and negative controls, respectively. The half-life of AIP-1
mRNA was observed to be 24 h in the AdGFP-transduced
cells, whereas its half-life was decreased to 12 h in AdQKI-
6–transduced cells (Figure 3A). The p27KIP1 mRNA stability
increased with the expression of QKI-6 (Figure 3B), as ob-
served previously (Larocque et al., 2005), whereas QKI-6
expression did not signiﬁcantly affect the half-life of the
-actin mRNA (Figure 3C). These ﬁndings suggest that ex-
pression of the QKI-6 isoform decreases the half-life of the
AIP-1 mRNA.
We showed previously that the QKI proteins bind a bi-
partite QRE with the sequence UAAY-(N1-20)-ACUAAY,
where N represents any nucleotide and Y is a pyrimidine
Figure 6. The decrease in AIP-1 coincides
with CNS myelination in rats. Rat pup brains
taken at postnatal day 0, day 7, or day 14 were
homogenized in lysis buffer, and the RNA was
extracted using TRIzol or Laemmli buffer for
Western blotting. RNA was analyzed by real-
time PCR with primers for QKI (A), MBP (B),
and AIP-1 (C). One-way analysis of variance
was performed; single asterisk denotes a p 
0.05. Protein samples were analyzed by West-
ern blotting (D) for -tubulin, AIP-1, QKI-6,
and MBP; -tubulin levels were used to con-
ﬁrm equivalent loading, and MBP expression
was used as a marker for OL differentiation.
The anti-QKI-6 antibody also recognizes QKI-7
and hence the doublet observed at day 14.
Changes in AIP-1 levels are shown and repre-
sent -tubulin–normalized values in compari-
son with day 0 OLs; quantiﬁcations were per-
formed using Scion-Image.
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Molecular Biology of the Cell 3034(Galarneau and Richard, 2005). We identiﬁed from nucleo-
tides 2902–2944 in the human and mouse AIP-1 mRNA the
sequence UAAU-(N26)-ACUAAU, reminiscent of a QRE. To
assess that this putative QRE is bound by QKI-6, we per-
formed electrophoretic mobility shift assays using in vitro-
transcribed RNA and recombinant GST QKI-6 (GST-QKI-6)
protein. As RNA probes, we used the wild-type AIP-1 3-
UTR QRE from nucleotides 2902–2944 and a mutant AIP-1
3-UTR QRE (AIP-1:mQRE) that harbors nucleotide substi-
tutions within the QRE that should prevent QKI-6 RNA
binding (Figure 4A). GST-QKI-6 bound in a dose-dependent
manner to the AIP-1:QRE but not to the AIP-1:mQRE (Fig-
ure 4B). These ﬁndings show that the AIP-1 mRNA harbors
a QRE that is bound by QKI-6.
As a control for viewing physiological interaction of
QKI-6 and AIP-1 mRNA, we examined whether QKI-6 can
coimmunoprecipitate with the AIP-1 mRNA in vitro.
Anti-QKI-6 and control (IgG) immunoprecipitations were
performed using AdQKI-6–transduced CRL2020 cell ex-
tracts. The coimmunoprecipitating RNAs were isolated,
and the presence of AIP-1, p27KIP1, and GAPDH mRNAs
was monitored by semiquantitative RT-PCR. We observed
that QKI-6 associated with both the mRNAs of AIP-1 and
p27KIP1 signiﬁcantly above background, but it did not
associate with the mRNA of the housekeeping gene
GAPDH (Figure 4C). These data show that the AIP-1
mRNA associates with QKI-6.
We next examined whether QKI-6 could regulate the
expression of a heterologous reporter gene harboring the
AIP-1 3-UTR. Expression vectors encoding wild-type
QKI-6 or a known RNA binding defective mutant (QKI-
6:V157E; Larocque et al., 2002) were transfected in
HEK293 cells with a luciferase reporter plasmid with or
without the AIP-1 3-UTR, as well as with an AIP-1 3-
UTR harboring a mutated QRE (Figure 5A). We observed
that luciferase expression of the luciferase AIP-1 3-UTR
reporter plasmid decreased in a dose-dependent manner
with the addition of QKI-6 but not with pcDNA or QKI-
6:V157E (Figure 5B). Moreover, the luciferase expression
was not modulated by QKI-6 in the absence of the AIP-1
Figure 7. AIP-1 expression decreases during
primary rat OL differentiation. (A) Primary
rat OPCs were induced to differentiate for the
indicated days, and the cells were lysed and
protein extracts were separated by SDS-poly-
acrylamide gel electrophoresis. The presence
of -tubulin, AIP-1, and MBP isoforms were
analyzed by immunoblotting. -Tubulin lev-
els were used to conﬁrm equivalent loading,
and MBP expression was used as a marker for
OL differentiation. Total RNA levels were iso-
lated from OLs differentiated for different
time points (day 0–4) and analyzed by real-
time PCR for changes in mRNA levels of
AIP-1 (B), MBP (C), and Id2 (D). Real-time
data represent three separate experiments.
One-way analysis of variance was performed
in comparison with day 0 samples; single as-
terisks denote a p  0.05 and double asterisks
denote a p  0.005. RNA half-life for Actin (E)
and AIP-1(F) was determined by actinomycin
D treatment for 0–24 h and compared be-
tween different time points of OL differenti-
ation (day 0 and day 4). Real-time data rep-
resent three separate experiments. Two-way
analysis of variance was performed in com-
parison with day 0 OPCs; double asterisks
denote a p  0.005.
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(Luc and Luc:AIP-1 mQRE; Figure 5B). These ﬁndings
show the requirement for the QRE within the AIP-1 3-
UTR and the QKI-6 RNA binding activity to mediate the
QKI-6–dependent AIP-1 repression.
AIP-1 Levels Decrease during CNS Myelination and OL
Differentiation
To elucidate whether AIP-1 is regulated during in vivo OL
differentiation and CNS myelination, we investigated
changes in AIP-1 levels in the brain of postnatal day 0
(P0), P7, and P14 wild-type rats. Total RNA was puriﬁed
and the mRNA levels of QKI, MBP (marker of OL differ-
entiation), and AIP-1 were analyzed by real-time RT-PCR
and normalized to GAPDH. During peak in vivo OL
differentiation and CNS myelination at P7 and P14, we
conﬁrmed that the QKI and MBP mRNA levels were
signiﬁcantly increased (Figure 6, A and B). AIP-1 mRNA
decreased gradually at P7 and P14 (Figure 6C). The de-
crease in AIP-1 protein level also was observed at P14 by
immunoblotting (Figure 6D). Moreover, the AIP-1 reduc-
tion at P14 also was observed by immunostaining O4-
positive OLs in rat brains (Supplemental Figure 1). These
ﬁndings show that AIP-1 mRNA and protein levels de-
crease in rat brains during in vivo OL differentiation and
CNS myelination.
We next examined whether the level of AIP-1 mRNA
and protein was regulated during in vitro OL differenti-
ation. AIP-1 was monitored by immunoblotting protein
extracts isolated from 0, 1, 2, and 4 d differentiated OLs.
We observed an approximately threefold reduction in
AIP-1 protein levels after4do fO Ld i f ferentiation by
using anti--tubulin immunoblotting as a loading control
and anti-MBP antibodies were used as a marker of OL
maturation (Figure 7A). In addition, puriﬁed primary rat
OLs were differentiated for 0, 1, 2, and 4 d and the AIP-1
mRNA was quantiﬁed by real-time RT-PCR and normal-
ized to GAPDH. We observed a gradual decrease in AIP-1
Figure 8. AIP-1 depleted OLs exhibit defects
in process extension. Primary rat OPCs were
differentiated for 1 d. The cells were then
immunostained for AIP-1 and coﬁlin (A) or
AIP-1 and phalloidin (B); the nuclei were vi-
sualized with 4,6-diamidino-2-phenylindole
(DAPI) staining, and the images were merged
on the right. Bars, 50 m for the full images
and 25 m for the branch point images. (C)
Knockdown efﬁciency of AIP-1 was veriﬁed
using Western blotting from total cell lysates
extracted after 24 h of differentiation, and
-tubulin was used as a loading control.
Changes in AIP-1 levels are shown and rep-
resent -tubulin normalized values; quantiﬁ-
cations were performed using Scion-Image.
(D) Day 1 differentiated cells transfected with
either siAIP-1 or sipGL2 were quantiﬁed for
their differentiation progress by counting the
number of secondary branching positive cells
in ﬁve ﬁelds of view per triplicate. One-way
analysis of variance was performed; single
asterisk denotes a p  0.05. (E) Primary rat
OPCs were cotransfected with siRNAs target-
ing AIP-1 or an irrelevant gene (luciferase;
sipGL2) and siGLO, a marker of transfected
cells. The siRNA-incubated cells were left in
proliferation media (day 0) or induced to dif-
ferentiate for 24 h, and the cells were then
immunostained with anti-A2B5 antibodies to
monitor process outgrowth. Bars, 50 m.
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day 4 of OL differentiation (Figure 7B). The mRNA levels
of MBP and the transcriptional repressor Id2 increased
and decreased, respectively, conﬁrming the proper differ-
entiation of the OLs (Figure 7, C and D). Together, these
ﬁndings show that AIP-1 mRNA and protein levels are
signiﬁcantly diminished during OL differentiation, sug-
gesting that the reduction in AIP-1 protein and mRNA
expression may be a prerequisite for OL branching and
maturation.
We monitored the half-life of the endogenous AIP-1
mRNA in the OL precursor cells (day 0) and in the mature
OLs (day 4), in which the levels of AIP-1 are elevated and
low, respectively (Figure 7A). OLs were incubated for up
to 24 h with actinomycin D, and the levels of -actin or
AIP-1 mRNA were monitored by real-time PCR and nor-
malized to GAPDH. We observed that the -actin mRNA
half-life was unaffected with OL differentiation (Figure
7E). However, the AIP-1 mRNA half-life was shorter (12
h) in day 4 mature OLs compared with 2 4hi nd a y0O L
precursor cultures (Figure 7F). These ﬁndings show that
the AIP-1 half-life decreases during OL differentiation.
AIP-1 Localization with Coﬁlin and Actin Filaments
in OLs
AIP-1 is known to colocalize with coﬁlin and actin ﬁlaments
(Ono, 2003). To examine whether AIP-1 is localized with
coﬁlin in OLs, we coimmunostained differentiated OLs with
anti-AIP-1 and anti-coﬁlin antibodies, and the cells were
visualized by ﬂuorescence microscopy. Indeed, as expected,
both AIP-1 and coﬁlin localized diffusely throughout OLs
and the staining was enriched at branch points (Figure 8A).
Moreover, similar staining was visualized with actin ﬁla-
ments by using phalloidin costained with AIP-1 (Figure 8B).
These ﬁnding show that AIP-1 localization in OLs is similar
to what has been observed in neurons stained with actin-
depolymerizing factor (ADF)/coﬁlin (Sarmiere and Bam-
burg, 2004), consistent with AIP-1 being a regulator cofactor
for actin remodeling with ADF/coﬁlin in OLs.
AIP-1 Is Required for OL Process Extension
We next investigated whether the presence of AIP-1 in the
immature OL precursor cells was required for OL process
extension. Immature OL precursor cells were transfected
with siRNA targeting AIP-1 (siAIP-1) or a control siRNA
targeting an irrelevant gene (luciferase; sipGL2). siGLO also
was used as a marker to visualize transfected cells, which
showed staining similar to previously reported results (Xian
et al., 2005). We observed an 30% knockdown of AIP-1 in
the entire immature primary OL precursor cell culture (Fig-
ure 8C). The number of secondary branching was assessed
from undifferentiated and differentiated siGLO-positive
OLs. We observed that siAIP-1–transfected OLs were signif-
icantly impaired in process extension compared with the
control OL cultures (Figure 8, D and E). These ﬁndings
suggest that AIP-1 is required for OL process extension.
We next analyzed whether AIP-1 levels are affected in
qkv/qkv mice, because these mice have been characterized
previously to lack the expression of the QKI-6 and QKI-7
isoforms in OLs (Hardy et al., 1996b). Thus, we examined
whether the AIP-1 expression was affected in the OLs of
qkv/qkv mice. Because of mosaic expression patterns of the
QKI isoforms in the brains of qkv/qkv mice (Hardy et al.,
1996b), we resorted to immunoﬂuorescence to examine the
expression of AIP-1 in OLs. We observed that the O4-posi-
tive OLs of 14-d-old qkv/qkv mice mouse pups had an ap-
proximately twofold increase in AIP-1 protein level com-
pared with OLs from qkv/ mice (Figure 9, A and B). These
ﬁndings suggest that the QKI isoforms regulate AIP-1 in
mouse OLs.
DISCUSSION
Here, we identiﬁed the mRNA of AIP-1, a regulatory
protein for coﬁlin during actin ﬁlament severing and de-
polymerization (Ono, 2003), as an RNA target for the
QKI-6 RNA-binding protein. The AIP-1 mRNA was
bound by QKI-6 in the 3-UTR, promoting AIP-1 mRNA
destabilization and resulting in lower AIP-1 protein lev-
Figure 9. Increased AIP-1 expression in qkv/
qkv mice. Brains were harvested from qkv/qkv
mice and qkv/ mice at postnatal day 14 and
stained for AIP-1, O4, and 4,6-diamidino-2-
phenylindole (DAPI); merged images are pre-
sented on the right (A). Images were taken in
the cerebral cortex. Bars, 50 m. (B) Immuno-
staining was quantiﬁed using AxioVision
4.8.1 software by standardizing levels of
AIP-1 signal to O4 signal; ﬁve ﬁelds of view
were used for each genotype. One-way anal-
ysis of variance was performed; single aster-
isk denotes a p  0.05.
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Vol. 21, September 1, 2010 3037els. We show the requirement for the QRE within the
AIP-1 3-UTR residing from nucleotides 2902–2944 by
using a luciferase reporter gene, and we also show that
QKI-6 RNA binding activity is required to mediate the
QKI-6–dependent AIP-1 repression. QKI-6 and QKI-7 are
up-regulated during murine CNS myelination and OL
differentiation (Ebersole et al., 1996b). We observed that
AIP-1 mRNA and protein levels decrease in rat brains
during in vivo OL differentiation and CNS myelination,
consistent with AIP-1 mRNA being an in vivo target of
QKI-6. Furthermore, qkv/qkv mice that lack QKI-6 and
QKI-7 within its OLs (Hardy et al., 1996b), had an in-
creased level of AIP-1 in OLs. Moreover, we observe a
decrease in AIP-1 mRNA and protein levels during in
vitro OL differentiation. AIP-1 reduction with siRNA in
the immature OL precursor cells impaired OL process
outgrowth, as seen by the reduction in secondary branch-
ing. Together, these ﬁndings suggest that the QKI RNA-
binding proteins regulate OL differentiation by modulat-
ing the expression of AIP-1.
The QKI proteins exhibit multiple RNA functions in-
cluding mRNA stability, mRNA export, and alternative
splicing (Chenard and Richard, 2008). We have shown
previously that the p27KIP1 mRNA is stabilized with QKI-
6/7 expression (Larocque et al., 2005), and we now show
that QKI-6 also functions in reducing the half-life of the
AIP-1 mRNA. Although we have not yet fully elucidated
the mechanism behind QKI-6 destabilization of AIP-1
mRNA, we suspect that this effect may be due to compe-
tition for mRNA binding between QKI-6 and mRNA-
stabilizing factors. To this end, we have observed several
sequences neighboring QKI-6 QRE on AIP-1 mRNA that
are reminiscent of HuR recognition sites (Brennan and
Steitz, 2001). We thus suggest that QKI-6 binds to the
AIP-1 QRE and prevents stabilizing factors such as HuR
(Brennan and Steitz, 2001) from binding, leading to the
observed reduction in AIP-1 half-life.
The highly regulated process of actin polymerization and
depolymerization is important in many physiological pro-
cesses, such as cytokinesis, motility, cell polarity, endocyto-
sis, and differentiation (Pak et al., 2008). AIP-1, also called
WDR1 (tryptophan-aspartate repeat protein 1), interacts
with ADF and coﬁlin–actin complexes to facilitate actin ﬁl-
ament severing and accelerate depolymerization (Ono,
2003). AIP-1 was identiﬁed to be regulated by acoustic over-
stimulation in the chick basilar papilla and for its association
with actin (Adler et al., 1999). The AIP-1 homologue in
Caenorhabditis elegans (Unc078) is a regulator of actin ﬁla-
ment organization during myoﬁbril development (Ono,
2001; Mohri et al., 2006). AIP-1-null mice are embryonic
lethal; however, hypomorphic alleles have been generated
and these mice develop macrothrombocytopenia and auto-
inﬂammatory disease (Kile et al., 2007). This study also iden-
tiﬁed AIP-1 in the actin dynamics of megakaryocytes and
neutrophils (Kile et al., 2007). Although a role for AIP-1 in
neuronal function was not reported, a role for coﬁlin 1 was
demonstrated in neuronal growth and neural crest cell mi-
gration (Bellenchi et al., 2007).
Considerable information is known about the cytoskel-
eton in OL differentiation and myelination (Bauer et al.,
2009) and on the function of RNA-binding proteins in
regulation of the cytoskeleton (Carson et al., 2008). For
example, OL process outgrowth has been shown to be
impaired in cells with reduced Mayven and its related
protein (MRP2) expression (Williams et al., 2005; Jiang et
al., 2007). As a modulator of actin disassembly, AIP-1 is
expected to be required for only a short period or in bursts
(Kueh et al., 2008). This short stage of rapid actin disas-
sembly would allow the cell to be primed for new actin
ﬁlament formation and eventually new cell structure and
morphology. The observed decrease in AIP-1 expression
levels paralleled the increase in QKI expression during
OL differentiation and CNS myelination. Global analysis
of gene expression in differentiating OLs revealed that
AIP-1 mRNA levels decrease during differentiation (Ca-
hoy et al., 2008), consistent with our present observations.
In addition, our observations in rat brains further provide
evidence of AIP-1 importance during development as well
as the role QKI plays in AIP-1 regulation.
AIP-1 has been shown to be required for cell shape mor-
phology changes, mainly cell ﬂattening (Ono, 2003). This
phenomenon is a response probably needed during OL dif-
Table 2. QREs identiﬁed in the putative QKI-6 targets
Gene Accession no. QRE sequence
ACO2 NM_001098 (1030) ACUAAUUGAAAUUAAC (1045)–CDSa
ACTB NM_173979 (1622) ACAAAUUUUGUUUUUAAU (1640)–3-UTR
ACTG1 NM_001614 None
AIP-1 NM_017491 (2903) UAAU-N26-ACUAAU (2940)–3-UTR
ANXA2 NM_001002858 (533) ACCAAC-N17-UAAC (560)–CDS
CAPZB NM_004930 (1315) UAAA-N17-ACUAAC (1341)–3-UTR
CCT6A NM_001762 (636) ACUAAA-N25-UAAC (671)–CDS
Eef2 NM_001961 (2972) ACUAAUUUUAAC (2983)–3-UTR
GANAB NM_198334 (1570) ACUAAU-N23-UAAC (1603)–CDS
GSN NM_001127662 (1410) ACUACC-N24-UAAU (1444)–CDS
HNRNPH3 NM_012207 (865) UAAU-N11-ACUAAA (886)–CDS
HSPA2/8 NM_021979 (2674) ACUAAA-N13-UAAU (2696)–3-UTR
HSPD1 NM_002156 (1867) ACUAGU-N13-UAAU (1890)–3-UTR
Lamin B1 NM_005573 (2476) UAAU-N20-ACUAGC (2506)–3-UTR
NPM1 NM_002520 (311) ACUAAA-N30-UAAU (350)–CDS
PKM2 NM_182470 (2133) ACUCACUCUGGGCUGUAAC (2152)–3-UTR
PYGB NM_002862 (3413) UAAC-N16-ACUAGC (3439)–3-UTR
TPI NM_000365 (990) UAAUGGUUGGAACUAAA (1006)–3-UTR
TPM3 NM_152263 (1607) UAAGAUUGACUAAU (1621)–3-UTR
VDAC2 NM_003375 (736) ACUAAUGUCAAC (748)–CDS
XRCC2 NM_005431 (2167) UAAUUAAACUAAA (2199)–3-UTR
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AIP-1 and coﬁlin show a very similar localization through-
out OLs, with the staining being enriched at branch points.
This evidence together with our ﬁndings of reduction in
AIP-1 during late stages of differentiation, suggests that
AIP-1 may be required for restructuring of OL cytoskeleton
for process outgrowth.
RNA-binding proteins are known to regulate a large array
of mRNA targets within a conserved network to provide a
rapid response to cellular needs (Keene and Lager, 2005).
Previously, QKI has been reported to bind and regulate
mRNA levels of several targets involved in OL differentia-
tion, such as p27KIP1 (Larocque et al., 2005), MBP (Li et al.,
2000; Larocque et al., 2002; Ryder and Williamson, 2004),
myelin-associated glycoprotein (Wu et al., 2002), and
MAP1B (Zhao et al., 2006a). Our analysis by 2D-DIGE has
led to identiﬁcation of several cytoskeletal proteins, includ-
ing AIP-1, TPM1, ACTG1, and lamin B1 that are regulated
by QKI-6 (Table 1). This interaction network is strengthened
by our evidence that all of the proposed cytoskeletal targets
contain a QRE site in their coding region or 3-UTR (Table 2).
These observations are consistent with cell adhesion as be-
ing a major annotation category of QKI mRNA targets (Ga-
larneau and Richard, 2005). Although only AIP-1 mRNA has
been conﬁrmed as a target of QKI, we believe that we have
uncovered the involvement of the QKI isoforms within a
larger subset of cytoskeletal proteins, allowing regulation of
morphological changes in OLs. Our ﬁndings provide a new
regulatory network in OLs and further demonstrate a role
for the QKI isoforms in OL function.
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